SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-122085
Filing Date
2016-05-19
Accepted
2016-05-19 16:04:05
Documents
3
Period of Report
2016-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-11792_18k.htm 8-K 28898
2 EX-1.1 a16-11792_1ex1d1.htm EX-1.1 296035
3 EX-5.1 a16-11792_1ex5d1.htm EX-5.1 11844
  Complete submission text file 0001104659-16-122085.txt   338118
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 161663209
SIC: 2835 In Vitro & In Vivo Diagnostic Substances